logo

For the Inventor, By the Inventor

Irvine, CA, United States of America

Allergan, Inc.


USPTO Granted Patents = 2,287

% Expired Patents = 24.4



Trademarks = 158

Forward Citations = 50,629

Loading Chart...
Loading Chart...

884 inventors (with patents filed for the assignee):

goldMedal Michael E Garst (189 out of 212 patents)

silverMedal Roshantha A Chandraratna (156 out of 291 patents)

bronzeMedal John E Donello (135 out of 136 patents)

4.  Robert M Burk (134 out of 166 patents)

5.  Ken Chow (120 out of 124 patents)

6.  Kei Roger Aoki (117 out of 126 patents)

7.  Richard L Beard (117 out of 138 patents)

8.  David W Old (111 out of 115 patents)

9.  Lance Steward (101 out of 102 patents)

10.  David Frederick Woodward (98 out of 113 patents)

11.  Patrick Michael Hughes (83 out of 90 patents)

12.  Daniel W Gil (75 out of 84 patents)

13.  Ester Fernandez-Salas (72 out of 76 patents)

14.  Larry Allen Wheeler (68 out of 76 patents)

15.  James Nienyuan Chang (64 out of 68 patents)


Core Competencies:
Hyaluronic Acid
Botulinum Toxin
Tissue Augmentation
Injection Devices
Dermal Filling
Soft Tissue
Pharmaceutical Compositions
Microneedles
Ocular Conditions
Anti-Microbial Efficacy
Prostaglandin Receptors
Biodegradable Implants

2,287 patents:

1. 12599699 - Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation (2026-04-14),
2. 12527816 - Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity (2026-01-20),
3. 12409211 - Non-protein Clostridial toxin compositions (2025-09-09),
4. 12241098 - Process and system for obtaining botulinum neurotoxin (2025-03-04),
5. 12208155 - Method for improving duration of effect of dermal filler treatment (2025-01-28),
6. 12171816 - Non-protein Clostridial toxin compositions (2024-12-24),
7. 12144847 - Non-protein clostridial toxin compositions (2024-11-19),
8. 12004995 - Intraocular implant with high loading of a prostamide (2024-06-11),
9. 11992668 - Injection device (2024-05-28),
10. D1027647 - Bottle holder (2024-05-21),
11. 11944533 - Implantable prostheses for tissue expansion (2024-04-02),
12. 11890457 - Aspiration and injection device (2024-02-06),
13. 11844878 - Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation (2023-12-19),
14. 11833269 - Hyaluronic acid-collagen matrices for dermal filling and volumizing applications (2023-12-05),
15. 11819541 - Injection paradigm for administration of botulinum toxins (2023-11-21),
Allergan, Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and commercialization of prescription medicines, medical aesthetics, and over-the-counter consumer healthcare products. With a focus on innovation, Allergan aims to enhance the health and well-being of people worldwide. They offer a diverse portfolio of products that address various therapeutic areas, including eye care, central nervous system, gastroenterology, and more. Allergan operates in over 100 countries and is committed to delivering high-quality healthcare solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Allergan, Inc.
2,287 Patents

#3 in Irvine, CA

#55 in California

#221 in US

#443 in the World

Irvine, CA (US)
Irvine, CA, United States of America

Allergan, Inc.

Forward Citations = 50,629

884 inventors:

goldMedal Michael E Garst (189 out of 212 patents)

silverMedal Roshantha A Chandraratna (156 out of 291 patents)

bronzeMedal John E Donello (135 out of 136 patents)

4.  Robert M Burk (134 out of 166 patents)

5.  Ken Chow (120 out of 124 patents)

Please report any incorrect information to [email protected]
Loading…